OTCQB
CLSH

CLS Holdings USA Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

CLS Holdings USA Inc Stock Price

Vitals

Today's Low:
$0.0479
Today's High:
$0.09
Open Price:
$0.085
52W Low:
$0.0348
52W High:
$0.5
Prev. Close:
$0.085
Volume:
1725930

Company Statistics

Market Cap.:
$3.44 million
Book Value:
-0.126
Revenue TTM:
$23.72 million
Operating Margin TTM:
-1.92%
Gross Profit TTM:
$11.54 million
Profit Margin:
-49.32%
Return on Assets TTM:
-1.98%
Return on Equity TTM:
-631.73%

Company Profile

CLS Holdings USA Inc had its IPO on under the ticker symbol CLSH.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. CLS Holdings USA Inc has a staff strength of 0 employees.

Stock update

Shares of CLS Holdings USA Inc opened at $0.09 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.05 - $0.09, and closed at $0.05.

This is a -38.24% slip from the previous day's closing price.

A total volume of 1,725,930 shares were traded at the close of the day’s session.

In the last one week, shares of CLS Holdings USA Inc have slipped by -30%.

CLS Holdings USA Inc's Key Ratios

CLS Holdings USA Inc has a market cap of $3.44 million, indicating a price to book ratio of 0.356 and a price to sales ratio of 0.2344.

In the last 12-months CLS Holdings USA Inc’s revenue was $23.72 million with a gross profit of $11.54 million and an EBITDA of $478954. The EBITDA ratio measures CLS Holdings USA Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CLS Holdings USA Inc’s operating margin was -1.92% while its return on assets stood at -1.98% with a return of equity of -631.73%.

In Q0.66666666666667, CLS Holdings USA Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 2.7%.

CLS Holdings USA Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.2 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CLS Holdings USA Inc’s profitability.

CLS Holdings USA Inc stock is trading at a EV to sales ratio of 1.3132 and a EV to EBITDA ratio of 22.6879. Its price to sales ratio in the trailing 12-months stood at 0.2344.

CLS Holdings USA Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$14.38 million
Total Liabilities
$16.27 million
Operating Cash Flow
$0
Capital Expenditure
$2989
Dividend Payout Ratio
0%

CLS Holdings USA Inc ended 2024 with $14.38 million in total assets and $0 in total liabilities. Its intangible assets were valued at $14.38 million while shareholder equity stood at $-9123679.00.

CLS Holdings USA Inc ended 2024 with $0 in deferred long-term liabilities, $16.27 million in other current liabilities, in common stock, $-105343764.00 in retained earnings and $557896.00 in goodwill. Its cash balance stood at $887812.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $5.78 million.

CLS Holdings USA Inc’s total current assets stands at $6.14 million while long-term investments were $590137.00 and short-term investments were $0. Its net receivables were $718382.00 compared to accounts payable of $2.15 million and inventory worth $4.35 million.

In 2024, CLS Holdings USA Inc's operating cash flow was $0 while its capital expenditure stood at $2989.

Comparatively, CLS Holdings USA Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.05
52-Week High
$0.5
52-Week Low
$0.0348
Analyst Target Price
$

CLS Holdings USA Inc stock is currently trading at $0.05 per share. It touched a 52-week high of $0.5 and a 52-week low of $0.5. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.07 and 200-day moving average was $0.06 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 2043.2% of the company’s stock are held by insiders while 3966.4% are held by institutions.

Frequently Asked Questions About CLS Holdings USA Inc

The stock symbol (also called stock or share ticker) of CLS Holdings USA Inc is CLSH

The IPO of CLS Holdings USA Inc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$393.82
-3.33
-0.84%
$1.83
0.01
+0.55%
$426.1
-1.25
-0.29%
$477.6
-7
-1.44%
$227.85
-13
-5.4%
$1.22
-0.06
-4.69%
$8.85
-0.4
-4.32%
$22.85
0.16
+0.71%
$39.81
-1.53
-3.7%
$224.3
-28.8
-11.38%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, such as oils, waxes, edibles, and shatters. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. In addition, it provides consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories; and toll processing services. The company offers its products under Oasis Cannabis and City Trees brand names. Its concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Miami, Florida.

Address

11767 South Dixie Highway, Miami, FL, United States, 33156